1. Home
  2. Stock quotes
  3. Stock ESSA Pharma
ESSA Pharma logo

ESSA Pharma EPIX

Quarterly report 2025-Q2
added 08-13-2025

report update icon

Country

 canadaCanada

IPO year

 -

Industry

 Biotechnology

Stock Exchange

 NASDAQ CAPITAL

Shares

 44.3 M

Market Cap[1]

 $ 8.86 M

EBITDA (LTM)

 -

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -0.58

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
AC Immune SA AC Immune SA
ACIU
 		$ 2.8 2.19 % $ 229 M Nasdaq Global Market schweizSchweiz
ADiTx Therapeutics ADiTx Therapeutics
ADTX
 		$ 2.49 -11.39 % $ 32.8 K Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
Abeona Therapeutics Abeona Therapeutics
ABEO
 		$ 4.59 -4.08 % $ 98.1 M Nasdaq Capital Market usaUSA
ARCA biopharma ARCA biopharma
ABIO
 		- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		- - $ 26.5 M Nasdaq Global Select Market usaUSA
Akouos Akouos
AKUS
 		- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
 		$ 12.12 -1.58 % $ 3.74 B NYSE usaUSA
Axcella Health Axcella Health
AXLA
 		- -16.42 % $ 249 M Nasdaq Global Market usaUSA
Acer Therapeutics Acer Therapeutics
ACER
 		- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Armata Pharmaceuticals Armata Pharmaceuticals
ARMP
 		$ 5.37 -20.68 % $ 194 M NYSE American usaUSA
Atreca Atreca
BCEL
 		- -11.76 % $ 5.79 M Nasdaq Global Select Market usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
 		- -2.5 % $ 5.88 M Nasdaq Capital Market usaUSA
argenx SE argenx SE
ARGX
 		$ 919.62 2.76 % $ 25 B Nasdaq Global Select Market niderlandNiderland
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
 		$ 203.0 -3.72 % $ 5 B Nasdaq Global Select Market danmarkDanmark
Achieve Life Sciences Achieve Life Sciences
ACHV
 		$ 4.64 -0.32 % $ 92 M Nasdaq Capital Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Acorda Therapeutics Acorda Therapeutics
ACOR
 		- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
 		$ 3.36 2.73 % $ 8.08 B Nasdaq Capital Market australiaAustralia
Acasti Pharma Acasti Pharma
ACST
 		- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
 		- -74.18 % $ 955 K Nasdaq Capital Market usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
 		$ 3.29 -1.5 % $ 908 M Nasdaq Capital Market israelIsrael
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
 		$ 54.27 -1.38 % $ 10.3 B Nasdaq Global Select Market,SPB usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
 		- -15.15 % $ 60.3 M Nasdaq Global Select Market britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		- - $ 40.3 B Nasdaq Global Select Market usaUSA
Baudax Bio Baudax Bio
BXRX
 		- 0.59 % $ 63 K Nasdaq Capital Market usaUSA
AbbVie AbbVie
ABBV
 		$ 224.99 -0.01 % $ 398 B NYSE,SPB usaUSA
Cara Therapeutics Cara Therapeutics
CARA
 		- -3.03 % $ 260 M Nasdaq Global Market,SPB usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
 		- - $ 3.45 B Nasdaq Global Select Market usaUSA
ChemoCentryx ChemoCentryx
CCXI
 		- - $ 3.74 B Nasdaq Global Select Market,SPB usaUSA
BioNTech SE BioNTech SE
BNTX
 		$ 96.22 -1.21 % $ 27.2 B Nasdaq Global Select Market germanyGermany
Codiak BioSciences Codiak BioSciences
CDAK
 		- -55.98 % $ 2.15 M Nasdaq Global Market usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
 		$ 18.75 -0.48 % $ 2.76 B Nasdaq Global Select Market,SPB usaUSA
Avid Bioservices Avid Bioservices
CDMO
 		- - $ 789 M Nasdaq Capital Market usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
 		$ 1.92 -7.01 % $ 4.87 M Nasdaq Global Select Market,SPB usaUSA
Biogen Biogen
BIIB
 		$ 179.76 1.11 % $ 26.2 B Nasdaq Global Select Market,SPB usaUSA
Cerevel Therapeutics Holdings Cerevel Therapeutics Holdings
CERE
 		- - $ 7.29 B Nasdaq Capital Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
 		- -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Beam Therapeutics Beam Therapeutics
BEAM
 		$ 23.52 -2.22 % $ 1.94 B Nasdaq Global Select Market usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
 		$ 3.45 -0.72 % $ 1.02 B Nasdaq Global Select Market canadaCanada
Cabaletta Bio Cabaletta Bio
CABA
 		$ 2.37 -2.67 % $ 2.77 M Nasdaq Global Select Market usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
 		- - $ 25.3 M Nasdaq Global Market usaUSA
Celsion Corporation Celsion Corporation
CLSN
 		- -6.63 % $ 13.9 M Nasdaq Capital Market usaUSA
Clovis Oncology Clovis Oncology
CLVS
 		- -7.23 % $ 13 M Nasdaq Global Select Market usaUSA
Advaxis Advaxis
ADXS
 		- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		- - $ 231 M Nasdaq Global Market usaUSA
Chimerix Chimerix
CMRX
 		- - $ 756 M Nasdaq Global Select Market usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
 		- - $ 401 M Nasdaq Global Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.